ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 197 filers reported holding ANI PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $276,000 | +17.9% | 4,473 | +39.6% | 0.00% | -20.0% |
| Q3 2019 | $234,000 | -20.4% | 3,205 | -23.0% | 0.01% | -28.6% |
| Q1 2019 | $294,000 | +23.0% | 4,164 | -1.4% | 0.01% | +75.0% |
| Q3 2018 | $239,000 | -83.8% | 4,224 | -85.8% | 0.00% | -77.8% |
| Q1 2017 | $1,475,000 | +25.2% | 29,783 | +53.3% | 0.02% | +50.0% |
| Q4 2016 | $1,178,000 | – | 19,432 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |